HRT May Up Hearing Loss Risk in Postmenopausal Women

Longer duration of hormone therapy associated with hearing loss risk
Longer duration of hormone therapy associated with hearing loss risk

(HealthDay News) — Hearing loss is linked to several factors associated with menopause, according to research published online May 8 in Menopause.

The findings stem from a review of data from 80,972 women in the United States.

According to the investigators, one factor is age at menopause. An older age is tied to a higher risk of hearing loss. A second factor is the use of oral hormone therapy to treat some of the symptoms of menopause. The researchers also found that the longer a woman used hormone therapy, the greater the odds of hearing difficulties.

"The finding from this observational study that women who underwent menopause at a later age and used oral hormone therapy had greater hearing loss was unexpected but should lead to more testing in a randomized, clinical trial," JoAnn Pinkerton, M.D., executive director of the North American Menopause Society, said in a news release from the group. "Information about the potential effect on hearing is important to include in a discussion regarding the risks and benefits of hormone therapy for symptomatic menopausal women."

Related Articles

Abstract/Full Text (subscription or payment may be required)